Case Study MICR 410 - Hematology Spring, 2011 Case # 6 Monique Quiroz Mike Pehl Andrew Ho.

Slides:



Advertisements
Similar presentations
Hematopathology Lab December 12, Case 1 . Normal Peripheral Blood Smear.
Advertisements

Case Study #7 MICR 410 – Hematology Spring 2010 Erik Bayona, Rosa E. Loyola, Lien Pham.
TA OGUNLESI (FWACP)1 CHILDHOOD LEUKAEMIA. TA OGUNLESI (FWACP)2 LEUKAEMIA Heterogenous group of malignant disorders Characterised by uncontrolled clonal.
APLASTIC AND HYPOPLASTIC ANEMIAS
Hematology Case # 1 History of Present Illness
Case Study MICR Hematology Spring, 2011
Hematology RBC/WBC Case Studies
MLAB Hematology Keri Brophy-Martinez
NEOPLASTIC DISORDERS OF THE BONE MARROW
Acute leukemia Mohammed Al-matrafi.
CLL- Chronic Lymphocytic Leukemia
Chronic leukaemias Chronic myelogenous leukaemia Chronic myelogenous leukaemia Chronic lymphocytic leukaemia Chronic lymphocytic leukaemia.
Myeloproliferative Disorders (Neoplasm)II Dr. Ibrahim. A. Adam.
Normocytic Normochromic Anemias
GROUP CASE STUDY Dr. Nancy McQueen MICR Hematology Spring, 2011
Case Study MICR Hematology Spring, 2011 Case # Team members here Note: Embedded in your PowerPoint, you must address all questions in the case!
This lecture was conducted during the Nephrology Unit Grand Ground by Nephrology Registrar under Nephrology Division, Department of Medicine in King Saud.
Chapter 17 Chronic Leukemias.
Chronic Leukemia Dr. Rania Alhady Chronic Lymphocytic leukemia (CLL):
Chronic leukemias. Chronic myelogenous (granulocytic) leukemia Is characterized by an unregulated proliferation of myeloid elements in the bone marrow,
Chapter 25: Acute Lymphoblastic Leukemia. Causes a wide spectrum of syndromes – From involvement of bone marrow and peripheral blood(leukemias) to those.
Acute Myeloid Leukemias (AML)
NYU Medicine Grand Rounds Clinical Vignette Maryann Kwa, MD PGY-2 January 12, 2011 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Laboratory diagnosis of Anemia
Myeloprolifrative disorders -Chronic Myelogenouse Leukemia - Primary Poly Cythemia ( vira ) - Essential Thrombocythemia - Myelofibrose Myeloid Methaplasia.
MLAB Hematology Keri Brophy-Martinez
MLAB Hematology Keri Brophy-Martinez Unit 23: CHRONIC MYELOPROLIFERATIVE DISORDERS (MPD)
Myeloproliferative Disorders (MPD) concepts Neoplastic (clonal) disorders of hemopoietic stem cells Over-production of all cell lines, with usually one.
The Chronic Myeloproliferative Disorders (MPD) A JENABIAN MD.
Case Study MICR Hematology Spring, 2011 Case # 5 Hee Jin Kim, Hooman Nikizad and Arthur Omuro.
Leukemia.
Leukemia By: Gabie Gomez. What is Leukemia? Blood consists of plasma and three types of cells, each type has a special function. RBC, WBC and Platelets.
4th Year Medical Student KAU
Myelofibrosis Chronic idiopathic myelofibrosis Progressive fibrosis of the marrow & increase connective tissue element Agnogenic myeloid metaplasia  Extramedullary.
Hematology and Hematologic Malignancies
Chronic leukemia 1. Chronic Lymphocytic leukemia (CLL) * Definition: Chronic neoplastic disorder characterized by accumulation of small mature-looking.
Heterogeneous group of hematopoietic neoplasms Uncontrolled proliferation and decreased apoptotic activity with variable degrees of differentiation Composed.
..  Neoplastic proliferation of small mature appearing  lymphocytes and account 25% of leukemia  It is rare before 40 years of age, the median age.
MLAB Hematology Keri Brophy-Martinez
HEMATOPATHOLOGY MODULE Prepared by Emmanuel R. de la Fuente, M.D.
Acute Leukemia Kristine Krafts, M.D..
Myeloproliferative Diseases Mark D. Browning, M.D. Oncology/Hematology Associates February 24, 2016.
LEUKEMIA Dr. Omar Alshaer. Acute Leukemia.
Acute lymphoblastic leukemia in children
AML Clinical Presentation. Clinical Presentation: Symptoms Fatigue (50%) Anorexia and weight loss Fever with or without an identifiable infection (10%)
CHAPTER 7 DISORDERS OF BLOOD CELLS & VESSELS. HEMATOPOIESIS Generation of blood cells Lymphoid progenitor cells = lymphocytes (WBCs) Myeloid progenitor.
APLASTIC AND HYPOPLASTIC ANEMIAS Waggas Elaas. APLASTIC ANEMIA Aplastic anemia is a severe, life threatening syndrome in which production of erythrocytes,
Thrombocythemia Mark D. Browning, M.D. February 24, 2016.
Nada Mohamed Ahmed, MD, MT (ASCP)i. Objectives chronic myeloid leukaemia (CML) Haematopoietic malignancies Polycythemia vera (PV) Idiopathic myelofibrosis.
Leukemia An estimate reveals over 327,520 people in the U.S. are living with Leukemia. In India leukemia is ranked among the list of top cancers affecting.
MLAB 1415-Hematology Keri Brophy-Martinez
Acute Leukemia Kristine Krafts, M.D..
MYELOPROLIFERATIVE DISEASES
MLAB 1415-Hematology Keri Brophy-Martinez
MYELOPROLIFERATIVE DISORDERS
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
CHRONIC MYELOID LEUKEMIA (CML)
Leukemia Case 1.
Case Study ….
Chronic Leukemia Kristine Krafts, M.D..
CASE STUDY Leukemia.
Diagnostic Hematology
Leukemia An estimate reveals over 327,520 people in the U.S. are living with Leukemia. In India leukemia is ranked among the list of top cancers affecting.
Case Summary John a 4 year old boy ,complains of
Leukemia case (18).
Case study A 36-year-old woman presented with a two-month history of increasing fatigue and abdominal fullness with accompanying loss of appetite. There.
A Case Report Ahmad Adel A..
Neoplastic disorder.
Chronic Leukemia Dr. Noha Noufal.
LEUKEMIA CASE.
Presentation transcript:

Case Study MICR Hematology Spring, 2011 Case # 6 Monique Quiroz Mike Pehl Andrew Ho

Case Summary John, a 52-year-old man with hyperuricemia, was seen at the clinic for follow-up evaluation for splenomegaly. His palpable spleen, noted 18 months earlier, had been gradually enlarging. Originally he denied fatigue, fever, and discomfort. He was examined and a CBC was ordered. The results revealed leukocytosis, thrombocytosis, and anemia. Physical examination revealed a slightly enlarged liver and palpable spleen. Blood counts showed: Hb:11.6 g/dLMCV = 97 fl Normocytic Hct:35%MCHC = 33 Normochromic RBC:3.6 x10 12 /LLow WBC:26.2 x10 9 /LHigh Platlets:853 x10 6 /LHigh The blood cell differential showed marked anisocytosis, poikilocytosis with many teardrops, and numerous nucleated RBCs. Immature myeloid cells were found and large platelets. The blood cell differential showed marked anisocytosis, poikilocytosis with many teardrops, and numerous nucleated RBCs. Immature myeloid cells were found and large platelets. During subsequent visits John complained of fatigue, bone pain, abdominal pain and discomfort. During subsequent visits John complained of fatigue, bone pain, abdominal pain and discomfort.

Diagnostic Tests Bone marrow biopsy Bone marrow biopsy - moderate to marked hyperplasia, clusters of platelets, abnormal megakaryocyte morphology, and fibrotic marrow spaces -dry tap Cytogenetic analysis Cytogenetic analysis -trisomy 8

Key Information Pointing to Diagnosis Physical Examination Splenomegaly Splenomegaly Bone Pain Bone Pain Weakness/fatigue Weakness/fatigue Peripheral blood smear Immature myeloid cells Immature myeloid cells Large platelets Large platelets Anisocytosis Anisocytosis Poikilocytosis with many teardrops Poikilocytosis with many teardrops Nucleated RBCs Nucleated RBCs Bone marrow biopsy Dry tap Fibrotic marrow spaces Marked hyperplasia Clusters of platelets Abnormal megakaryocyte morphology Cytogenetic Testing Trisomy 8

What caused the splenomegaly? Extramedullary hematopoiesis Extramedullary hematopoiesis Culling of the teardrop RBC and immature cells Culling of the teardrop RBC and immature cells Note: His abdominal pain is most likely a result of both the extramedullary hematopoiesis occuring in the kidneys, liver, and spleen, as well as thrombosis of the vasculature associated with the gastroinstestinal tract.

The Diagnosis Myelofibrosis with myeloid metaplasia = MMM Middle aged Middle aged Anemia Anemia Hepatosplenomegaly Hepatosplenomegaly Leukocytosis Leukocytosis Thrombocytosis Thrombocytosis Bizarre, functional platelets Bizarre, functional platelets Hypercellular bone marrow Hypercellular bone marrow Fibrotic marrow spaces Fibrotic marrow spaces Hyperplasia Hyperplasia Clusters of platlets Clusters of platlets Abnormal megakaryocytes Abnormal megakaryocytes

Pathophysiology of Disease MMM Change in hematopoeitic precursor cells Increased hematopoesis Teardrop RBC as they squeeze out of the bone marrow Hypercellularity of bone marrow Associated bone pain and osteosclerosis Extramedullary hematopoesis Splenomegaly Fibrosis of bone marrow Anemia

Therapy and Prognosis for Disease MMM Therapy Immunosupressive therapy Slow down rapidly dividing hematopoetic cells Surgery for splenomegaly Blood transfusions Oral chemotherapy or low dose radiation Attack rapidly dividing hematopoetic cells Bone Marrow Transplant Prognosis Can terminate in acute mylocytic leukemia = AML

Prevention of Disease MMM Disease is idiopathic, so it is difficult to determine how to prevent it Disease is idiopathic, so it is difficult to determine how to prevent it Unfortunately patient shows genetic predisposition, so only preventative measures would be to avoid known carcinogens and have frequent blood analysis Unfortunately patient shows genetic predisposition, so only preventative measures would be to avoid known carcinogens and have frequent blood analysis

Take Home Message The diagnosis is myelofibrosis with myeloid metaplasia (extramedullary hematopoiesis) The diagnosis is myelofibrosis with myeloid metaplasia (extramedullary hematopoiesis) Typical symptoms are hepatosplenomegaly, anemia, bone pain. Typical symptoms are hepatosplenomegaly, anemia, bone pain. The cause of the disease is idiopathic. The cause of the disease is idiopathic. Diagnostic tests include bone marrow biopsy and cytogenetics. Diagnostic tests include bone marrow biopsy and cytogenetics. Treatment is supportive care, immunosuppressive therapy, and eventually a bone marrow transplant. Treatment is supportive care, immunosuppressive therapy, and eventually a bone marrow transplant. Prognosis is eventual progression to lethal AML. Prognosis is eventual progression to lethal AML. Prevention is nonexistant. Prevention is nonexistant.

References Mayo Clinic : Myelofibrosis Resource. Mayo Clinic : Myelofibrosis Resource. Harmening, D.M. Clinical Hematology and Fundamentals of Hemostasis. 5 th Edition. Philadelphia, PA. F.A. Davis Company Harmening, D.M. Clinical Hematology and Fundamentals of Hemostasis. 5 th Edition. Philadelphia, PA. F.A. Davis Company McQueen, N. (2011, May). Lecture 13. Neoplastic Disorders of the Bone Marrow. Micr 410. CSULA. McQueen, N. (2011, May). Lecture 13. Neoplastic Disorders of the Bone Marrow. Micr 410. CSULA.